Faculty Opinions recommendation of Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
Keyword(s):
2014 ◽
Vol 2
(5)
◽
pp. 369-384
◽
Keyword(s):
Keyword(s):
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
2019 ◽
Vol 7
(6)
◽
pp. 429-441
◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2013 ◽
Vol 15
(5)
◽
pp. 432-440
◽
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
